Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptococcal meningitis and AIDS

W G Powderly1

  • 1Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri 63110.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rifabutin induced vitritis in AIDS patients.

Ocular immunology and inflammation·2012
Same author

Progenitor cell types in HIV-1 infection: bioactivity and emerging targets for treatment.

Current HIV research·2009
Same author

Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.

HIV medicine·2009
Same author

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

HIV medicine·2008
Same author

Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

HIV medicine·2007
Same author

Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

Journal of viral hepatitis·2007
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Cryptococcal infections in individuals with human immunodeficiency virus (HIV) are reviewed, highlighting advances in treatment and management strategies for cryptococcal meningitis. Further research is needed to address remaining challenges in treating this opportunistic fungal infection.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Cryptococcal infection is a significant opportunistic infection in individuals with human immunodeficiency virus type 1 (HIV-1).
  • The advent of fluconazole and itraconazole has improved understanding of prognostic factors in HIV-associated cryptococcosis.
  • Management of cryptococcal meningitis in immunocompromised patients has evolved, influenced by pivotal clinical trials.

Purpose of the Study:

  • To provide a comprehensive review of current knowledge on cryptococcal infections in HIV-1-infected individuals.
  • To discuss the impact of antifungal agents on prognostic factors and patient management.
  • To outline progress and identify unresolved issues in the clinical investigation of cryptococcosis.

Main Methods:

Related Experiment Videos

  • Review of existing literature and clinical investigations.
  • Analysis of the impact of antifungal therapies like fluconazole and itraconazole.
  • Discussion of historical treatment guidelines, including the 1979 Mycosis Study Group trial.

    • Main Results:

    • Antifungal advancements have enhanced insight into prognostic factors for HIV-associated cryptococcal meningitis.
    • Established therapeutic strategies for cryptococcal meningitis have significantly altered patient management.
    • Clinical investigations have demonstrated progress but also highlighted persistent challenges.

    Conclusions:

    • Significant progress has been made in understanding and managing cryptococcal infections in HIV-1 patients.
    • Despite advancements, challenges remain in the comprehensive treatment and resolution of cryptococcosis.
    • Continued clinical investigation is essential to address the remaining problems in this field.